HDAC1 and pulmonary arterial hypertension: These results suggest that inhibition of HDAC1 alleviates pulmonary arterial remodeling, excessive ECM accumulation and the increase of RVSP and RVHI through restoring miR-34a level in MCT-induced PAH rats.